Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics (NQ: AKBA )

0.3652 -0.0280 (-7.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,019,960
Open 0.4000
Bid (Size) 0.3750 (7)
Ask (Size) 0.3899 (74)
Prev. Close 0.3932
Today's Range 0.3624 - 0.4111
52wk Range 0.3000 - 4.330
Shares Outstanding 174,537,458
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 06/20/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Akebia Therapeutics, Inc.. 
Via SBWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-85.09%
-85.09%
1 Month
+10.67%
+10.67%
3 Month
-84.91%
-84.91%
6 Month
-84.78%
-84.78%
1 Year
-91.26%
-91.26%

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
Why Are Akebia Therapeutics Shares Falling Today?
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Looking Into Akebia Therapeutics's Return On Capital Employed
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
73 Biggest Movers From Yesterday
Via Benzinga
41 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Expert Ratings for Akebia Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
30 Stocks Moving in Monday's Pre-Market Session
Via Benzinga
AKEBIA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Akebia Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
103 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
NASDAQ:AKBA Investor Notice: Deadline on May 13, 2022 in Lawsuit Against Akebia Therapeutics, Inc.
Via SBWire
AKBA FINAL DEADLINE: ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action - AKBA
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bronstein, Gewirtz & Grossman, LLC Reminds Akebia Therapeutics, Inc. (AKBA) Shareholders of Class Action and Encourages May 13, 2022 Deadline
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBA
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
AKBA INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA
Via NewMediaWire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA
Via NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.